Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

HealthTree Podcast for Multiple Myeloma: Teclistamab's Approval with Dr. Garfall

  • Broadcast in Health
HealthTree Podcast for MM

HealthTree Podcast for MM


Follow This Show

If you liked this show, you should follow HealthTree Podcast for MM.

Teclistamab is the first bispecific antibody to be FDA approved in mulitple myeloma. On this HealthTree Podcast for Multiple Myeloma episode, learn from Alfred Garfall, MD of the University of Pennsylvania about how it will be used in the clinic as an approved therapy. Our discussion will include who qualifies for this new treatments, when patients should consider using it, if it can be combined with other myeloma therapies, if the therapy is continuous or can be stopped, common side effects to expect, how it is administered (in and outpatient) and how the caregiver needs to be involved.  

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled